MANGALAM DRUGS AND ORGANICS
|
MANGALAM DRUGS AND ORGANICS Last 5 Year Income Statement History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹451 Cr | ₹385 Cr | ₹313 Cr | ₹259 Cr | ₹308 Cr |
Sales | ₹425 Cr | ₹380 Cr | ₹310 Cr | ₹252 Cr | ₹298 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | ₹22 Cr | - | - | - | - |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹3.70 Cr | ₹4.90 Cr | ₹3.47 Cr | ₹7.22 Cr | ₹9.75 Cr |
Less: Excise Duty | - | - | ₹31 Cr | ₹31 Cr | ₹28 Cr |
Net Sales | ₹451 Cr | ₹385 Cr | ₹282 Cr | ₹228 Cr | ₹279 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹-34 Cr | ₹-4.23 Cr | ₹17 Cr | ₹-15 Cr | ₹-14 Cr |
Raw Material Consumed | ₹340 Cr | ₹256 Cr | ₹178 Cr | ₹169 Cr | ₹181 Cr |
Opening Raw Materials | ₹27 Cr | ₹37 Cr | ₹28 Cr | ₹30 Cr | ₹19 Cr |
Purchases Raw Materials | ₹364 Cr | ₹246 Cr | ₹187 Cr | ₹167 Cr | ₹192 Cr |
Closing Raw Materials | ₹51 Cr | ₹27 Cr | ₹37 Cr | ₹28 Cr | ₹30 Cr |
Other Direct Purchases / Brought in cost | ₹1.31 Cr | - | - | ₹0.30 Cr | ₹0.18 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹23 Cr | ₹16 Cr | ₹14 Cr | ₹15 Cr | ₹14 Cr |
Electricity & Power | ₹23 Cr | ₹16 Cr | ₹14 Cr | ₹15 Cr | ₹14 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹37 Cr | ₹30 Cr | ₹26 Cr | ₹26 Cr | ₹23 Cr |
Salaries, Wages & Bonus | ₹35 Cr | ₹27 Cr | ₹24 Cr | ₹23 Cr | ₹20 Cr |
Contributions to EPF & Pension Funds | ₹0.85 Cr | ₹1.11 Cr | ₹0.90 Cr | ₹0.97 Cr | ₹1.92 Cr |
Workmen and Staff Welfare Expenses | ₹1.54 Cr | ₹1.34 Cr | ₹0.94 Cr | ₹0.97 Cr | ₹0.60 Cr |
Other Employees Cost | - | ₹0.34 Cr | ₹0.42 Cr | ₹0.54 Cr | ₹0.53 Cr |
Other Manufacturing Expenses | ₹19 Cr | ₹14 Cr | ₹9.77 Cr | ₹12 Cr | ₹15 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | - | - | ₹0.03 Cr | ₹0.02 Cr | ₹0.04 Cr |
Repairs and Maintenance | ₹3.45 Cr | ₹3.84 Cr | ₹2.35 Cr | ₹2.81 Cr | ₹6.03 Cr |
Packing Material Consumed | - | - | - | - | - |
Other Mfg Exp | ₹16 Cr | ₹10 Cr | ₹7.40 Cr | ₹9.20 Cr | ₹8.77 Cr |
General and Administration Expenses | ₹6.10 Cr | ₹6.05 Cr | ₹6.67 Cr | ₹7.59 Cr | ₹7.54 Cr |
Rent , Rates & Taxes | ₹0.81 Cr | ₹0.99 Cr | ₹1.02 Cr | ₹1.52 Cr | ₹1.06 Cr |
Insurance | ₹1.08 Cr | ₹0.90 Cr | ₹0.54 Cr | ₹0.56 Cr | ₹0.48 Cr |
Printing and stationery | ₹0.52 Cr | ₹0.45 Cr | ₹0.68 Cr | ₹0.60 Cr | ₹0.58 Cr |
Professional and legal fees | ₹1.86 Cr | ₹2.13 Cr | ₹2.05 Cr | ₹1.94 Cr | ₹2.64 Cr |
Traveling and conveyance | ₹0.54 Cr | ₹0.36 Cr | ₹0.79 Cr | ₹1.64 Cr | ₹1.76 Cr |
Other Administration | ₹1.82 Cr | ₹1.59 Cr | ₹2.39 Cr | ₹2.98 Cr | ₹2.79 Cr |
Selling and Distribution Expenses | ₹7.82 Cr | ₹7.61 Cr | ₹5.16 Cr | ₹3.96 Cr | ₹5.58 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | - | - | ₹0.02 Cr | ₹0.00 Cr | ₹0.79 Cr |
Miscellaneous Expenses | ₹2.22 Cr | ₹1.01 Cr | ₹1.42 Cr | ₹0.32 Cr | ₹0.51 Cr |
Bad debts /advances written off | - | - | - | - | - |
Provision for doubtful debts | - | - | - | - | - |
Losson disposal of fixed assets(net) | - | - | ₹0.05 Cr | ₹0.05 Cr | - |
Losson foreign exchange fluctuations | - | - | - | - | - |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹2.22 Cr | ₹1.01 Cr | ₹1.37 Cr | ₹0.27 Cr | ₹0.51 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹402 Cr | ₹327 Cr | ₹259 Cr | ₹218 Cr | ₹233 Cr |
Operating Profit (Excl OI) | ₹49 Cr | ₹58 Cr | ₹24 Cr | ₹9.68 Cr | ₹47 Cr |
Other Income | ₹0.09 Cr | - | ₹1.18 Cr | ₹0.32 Cr | ₹0.84 Cr |
Interest Received | - | - | ₹0.80 Cr | - | - |
Dividend Received | ₹0.00 Cr | - | - | ₹0.02 Cr | ₹0.02 Cr |
Profit on sale of Fixed Assets | - | - | - | - | ₹0.02 Cr |
Profits on sale of Investments | ₹0.09 Cr | - | - | - | ₹0.02 Cr |
Provision Written Back | - | - | - | ₹0.01 Cr | - |
Foreign Exchange Gains | - | - | - | - | - |
Others | - | - | ₹0.38 Cr | ₹0.29 Cr | ₹0.79 Cr |
Operating Profit | ₹49 Cr | ₹58 Cr | ₹25 Cr | ₹10.00 Cr | ₹48 Cr |
Interest | ₹11 Cr | ₹9.33 Cr | ₹10 Cr | ₹8.65 Cr | ₹12 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | ₹6.02 Cr | ₹5.84 Cr | - | - | - |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹3.96 Cr | ₹3.01 Cr | ₹3.91 Cr | ₹2.03 Cr | ₹3.18 Cr |
Other Interest | ₹1.18 Cr | ₹0.49 Cr | ₹6.50 Cr | ₹6.62 Cr | ₹8.61 Cr |
PBDT | ₹38 Cr | ₹49 Cr | ₹14 Cr | ₹1.35 Cr | ₹36 Cr |
Depreciation | ₹10 Cr | ₹9.18 Cr | ₹8.22 Cr | ₹7.09 Cr | ₹6.57 Cr |
Profit Before Taxation & Exceptional Items | ₹28 Cr | ₹40 Cr | ₹6.25 Cr | ₹-5.74 Cr | ₹29 Cr |
Exceptional Income / Expenses | - | - | - | - | - |
Profit Before Tax | ₹28 Cr | ₹40 Cr | ₹6.25 Cr | ₹-5.74 Cr | ₹29 Cr |
Provision for Tax | ₹8.08 Cr | ₹12 Cr | ₹-2.00 Cr | ₹2.29 Cr | ₹9.46 Cr |
Current Income Tax | ₹8.76 Cr | ₹9.27 Cr | ₹1.10 Cr | - | ₹8.59 Cr |
Deferred Tax | ₹-0.73 Cr | ₹2.28 Cr | ₹-2.05 Cr | ₹2.29 Cr | ₹2.86 Cr |
Other taxes | ₹0.05 Cr | - | ₹-1.05 Cr | ₹2.29 Cr | ₹-2.00 Cr |
Profit After Tax | ₹20 Cr | ₹28 Cr | ₹8.25 Cr | ₹-8.03 Cr | ₹20 Cr |
Extra items | - | - | - | - | - |
Minority Interest | - | - | - | - | - |
Share of Associate | - | - | - | - | - |
Other Consolidated Items | - | - | - | ₹-0.09 Cr | - |
Consolidated Net Profit | ₹20 Cr | ₹28 Cr | ₹8.25 Cr | ₹-8.12 Cr | ₹20 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹82 Cr | ₹55 Cr | ₹47 Cr | ₹55 Cr | ₹35 Cr |
Appropriations | ₹101 Cr | ₹83 Cr | ₹55 Cr | ₹47 Cr | ₹55 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | - |
Other Appropriation | ₹-0.12 Cr | ₹1.12 Cr | ₹-0.02 Cr | ₹-0.02 Cr | ₹-0.35 Cr |
Equity Dividend % | - | - | - | - | ₹5.00 |
Earnings Per Share | ₹12.42 | ₹17.67 | ₹5.21 | ₹-5.07 | ₹12.57 |
Adjusted EPS | ₹12.42 | ₹17.67 | ₹5.21 | ₹-5.07 | ₹12.57 |
Compare Income Statement of peers of MANGALAM DRUGS AND ORGANICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANGALAM DRUGS AND ORGANICS | ₹157.5 Cr | -0.4% | -21.3% | -8.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,311.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹108,623.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,134.3 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹97,408.4 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹92,794.9 Cr | 5% | 10.4% | 109.1% | Stock Analytics |
MANGALAM DRUGS AND ORGANICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANGALAM DRUGS AND ORGANICS | -0.4% |
-21.3% |
-8.1% |
SENSEX | -2.6% |
-0% |
21% |
You may also like the below Video Courses